Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury | MicrobiomeTrials← Back to trialsNCT07635277
Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06-07Est. Completion: 2026-11-30
Enrollment target: 40 participants Locations- West China Hospital of Sichuan University, Chengdu, Sichuan, China
- Jintang County First People's Hospital, Chengdu, Sichuan, China
Other microbiome trials you might be interested in
CardiotoxicityCancerCardiac ArrhythmiaLeft Ventricular DysfunctionBreast CancerMultiple Myeloma
This pilot study will evaluate the validity and feasibility of ambulatory cardiac monitoring to identify markers of card…
Minneapolis, United StatesEst. completion Mar 1, 2028
Post-COVID-19 ConditionUlcerative ColitisCrohn DiseaseCalciphylaxisFrostbite
Acute COVID-19
Pyoderma Gangrenosum
Pterygium
Hypospadias
Head Trauma
Pneumatosis Intestinalis
Ischemic Bowel
Raynaud Syndrome
Malignant Otitis Externa
Nonarteritic Anterior Ischemic Optic Neuropathy
Central Retinal Vein Occlusion
Femoral Head Necrosis
Invasive Fungal Infection
Chronic Anal Fissure
Vasculitic Ulcer
Graft-vs-Host Disease
Decubitus Ulcer
Greater Trochanteric Pain Syndrome
Rectovaginal Fistula
Pouchitis
Tinnitus
Clostridium Enterocolitis
Branch Retinal Artery Occlusion
Axonotmesis
Multiple Sclerosis
Inclusion Body Myositis
Epidermolysis Bullosa (EB)
Osteonecrosis
Ulcer Ischemic
Avascular Necrosis of Bone
Prosthesis Related Infections
Facial Filler Injections
Cystitis Chronic
Ligament Injury
Anastomosis, Leaking
Cartilage Injury
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., c…
Multiple LocationsEst. completion Dec 2035